Browsing by Author Kiortsis, D. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 21 to 40 of 81 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in healthy obese womenTzotzas, T.; Filippatos, T. D.; Triantos, A.; Bruckert, E.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015-
Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndromeFilippatos, T. D.; Kiortsis, D. N.; Tselepis, A. D.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
Effects of Cupressus sempervirens cone extract on lipid parameters in Wistar ratsKarkabounas, S.; Kiortsis, D. N.; Zelovitis, J.; Skafida, P.; Demetzos, C.; Malamas, M.; Elisaf, M. S.; Evangelou, A.24-Nov-2015-
The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemiaNakou, E. S.; Filippatos, T. D.; Kiortsis, D. N.; Derdemezis, C. S.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic SyndromeDerdemezis, C. S.; Filippatos, T. D.; Nakou, E. S.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitisKiortsis, D. N.; Mavridis, A. K.; Vasakos, S.; Nikas, S. N.; Drosos, A. A.24-Nov-2015-
Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitisKiortsis, D. N.; Mavridis, A. K.; Filippatos, T. D.; Vasakos, S.; Nikas, S. N.; Drosos, A. A.24-Nov-2015-
Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesiasKonitsiotis, S.; Tsironis, C.; Kiortsis, D. N.; Evangelou, A.24-Nov-2015-
Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli studyFilippatos, T. D.; Kiortsis, D. N.; Gazi, I.; Liberopoulos, E. N.; Georgoula, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndromeFilippatos, T. D.; Liberopoulos, E. N.; Kostapanos, M.; Gazi, I. F.; Papavasiliou, E. C.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
The effects of orlistat on metabolic parameters and other cardiovascular risk factorsKiortsis, D. N.; Filippatos, T. D.; Elisaf, M. S.24-Nov-2015-
Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised studyKiortsis, D. N.; Tsouli, S.; Filippatos, T. D.; Konitsiotis, S.; Elisaf, M. S.24-Nov-2015-
Effects of sibutramine plus verapamil SR/trandolapril combination on blood pressure and metabolic parameters in obese patients with mild hypertensionFilippatos, T. D.; Nakou, E.; Liberopoulos, E. N.; Derdemezis, C. S.; Georgoula, M.; Tselepis, A. D.; Elisaf, M. S.; Kiortsis, D. N.24-Nov-2015-
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patientsNakou, E.; Filippatos, T. D.; Liberopoulos, E. N.; Tselepis, A. D.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisar, M. S.24-Nov-2015-
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patientsNakou, E.; Filippatos, T. D.; Liberopoulos, E. N.; Tselepis, A. D.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosisKiortsis, D. N.; Elisaf, M. S.24-Nov-2015-
The effects of weight loss on Lp-PLA2 activity and low density lipoprotein (LDL) phenotype in obese womenFilippatos, T. D.; Tzotzas, T.; Kiortsis, D. N.; Triantos, A.; Karamouzis, M.; Tselepis, A.24-Nov-2015-
Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patientsKiortsis, D. N.; Giral, P.; Bruckert, E.; Turpin, G.24-Nov-2015-
Growth Factors and Adipocytokines in Prepubertal Children Born Small for Gestational AgeChalla, A. S.; Evagelidou, E. N.; Cholevas, V. I.; Kiortsis, D. N.; Giapros, V. I.; Drougia, A. A.; Andronikou, S. K.24-Nov-2015-